Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
- PMID: 16914401
- DOI: 10.1016/S1474-4422(06)70537-3
Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study
Abstract
Background: Several vascular risk factors are associated with dementia. We sought to develop a simple method for the prediction of the risk of late-life dementia in people of middle age on the basis of their risk profiles.
Methods: Data were used from the population-based CAIDE study, which included 1409 individuals who were studied in midlife and re-examined 20 years later for signs of dementia. Several midlife vascular risk factors were studied to create the scoring tool. The score values were estimated on the basis of beta coefficients and the dementia risk score was the sum of these individual scores (range 0-15).
Findings: Occurrence of dementia during the 20 years of follow-up was 4%. Future dementia was significantly predicted by high age (> or = 47 years), low education (< 10 years), hypertension, hypercholesterolaemia, and obesity. The dementia risk score predicted dementia well (area under curve 0.77; 95% CI 0.71-0.83). The risk of dementia according to the categories of the dementia risk score was 1.0% for those with a score of 0-5, 1.9% for a score of 6-7, 4.2% for a score of 8-9, 7.4% for a score of 10-11, and 16.4% for a score of 12-15. When the cut-off of 9 points or more was applied the sensitivity was 0.77, the specificity was 0.63, and the negative predictive value was 0.98.
Interpretation: The dementia risk score is a novel approach for the prediction of dementia risk, but should be validated and further improved to increase its predictive value. This approach highlights the role of vascular factors in the development of dementia and could help to identify individuals who might benefit from intensive lifestyle consultations and pharmacological interventions.
Comment in
-
Defusing the dementia time bomb.Lancet Neurol. 2006 Sep;5(9):721. doi: 10.1016/S1474-4422(06)70529-4. Lancet Neurol. 2006. PMID: 16914398 No abstract available.
Similar articles
-
Midlife CAIDE dementia risk score and dementia-related brain changes up to 30 years later on magnetic resonance imaging.J Alzheimers Dis. 2015;44(1):93-101. doi: 10.3233/JAD-140924. J Alzheimers Dis. 2015. PMID: 25190628
-
Midlife risk score for the prediction of dementia four decades later.Alzheimers Dement. 2014 Sep;10(5):562-70. doi: 10.1016/j.jalz.2013.05.1772. Epub 2013 Sep 10. Alzheimers Dement. 2014. PMID: 24035147
-
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.Arch Neurol. 2005 Oct;62(10):1556-60. doi: 10.1001/archneur.62.10.1556. Arch Neurol. 2005. PMID: 16216938
-
Prevention of Alzheimer's disease: moving backward through the lifespan.J Alzheimers Dis. 2013;33 Suppl 1:S465-9. doi: 10.3233/JAD-2012-129021. J Alzheimers Dis. 2013. PMID: 22751171 Review.
-
Preventing dementia: how lifestyle in midlife affects risk.Curr Opin Psychiatry. 2014 Mar;27(2):149-57. doi: 10.1097/YCO.0000000000000045. Curr Opin Psychiatry. 2014. PMID: 24441418 Review.
Cited by
-
Establishing a machine learning dementia progression prediction model with multiple integrated data.BMC Med Res Methodol. 2024 Nov 22;24(1):288. doi: 10.1186/s12874-024-02411-2. BMC Med Res Methodol. 2024. PMID: 39578765 Free PMC article.
-
A digitally supported multimodal lifestyle program to promote brain health among older adults (the LETHE randomized controlled feasibility trial): study design, progress, and first results.Alzheimers Res Ther. 2024 Nov 21;16(1):252. doi: 10.1186/s13195-024-01615-4. Alzheimers Res Ther. 2024. PMID: 39574193 Free PMC article. Clinical Trial.
-
Modifiable dementia risk associated with smaller white matter volume and altered 1/f aperiodic brain activity: cross-sectional insights from the LEISURE study.Age Ageing. 2024 Nov 4;53(11):afae243. doi: 10.1093/ageing/afae243. Age Ageing. 2024. PMID: 39523601 Free PMC article.
-
Role of glucagon-like peptide-1 receptor agonists in Alzheimer's disease and Parkinson's disease.J Biomed Sci. 2024 Nov 5;31(1):102. doi: 10.1186/s12929-024-01090-x. J Biomed Sci. 2024. PMID: 39501255 Free PMC article. Review.
-
A single risk assessment for the most common diseases of ageing, developed and validated on 10 cohort studies.BMC Med. 2024 Oct 31;22(1):501. doi: 10.1186/s12916-024-03711-6. BMC Med. 2024. PMID: 39482675 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
